MRNA

Moderna, Inc. (MRNA)

Last Price$35.55.3%
Market Cap$13.7B
LTM EPS
($9.29)
EPS growth
(25.3%)
Ben Graham Fair Value
$334.6
Undervalued (Ben Graham formula)
841.9%
Stock quality
6/10
Good

MRNA Ben Graham Fair Value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

MRNA EPS growth & Dividend Yield

Crunching data... Almost there!

MRNA vs Peer Set: Ben Graham Fair Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for MRNA

FAQ

What is Moderna, Inc.'s fair value according to the Ben Graham formula?

As of Dec 31, 2024, Moderna, Inc.'s fair value using the Ben Graham formula is $334.6 per share. This is calculated using Ben Graham formula, where EPS is ($9.3) and BVPS (Book Value Per Share) is $28.4. The current price of $35.5 suggests Moderna, Inc. may be overvalued by this conservative metric.

What is Moderna, Inc. earnings per share (EPS)?

Moderna, Inc. earnings per share (EPS) for the twelve months ending Dec 31, 2024, was ($9.3), a (25.3%) growth year-over-year.

What is Moderna, Inc.'s margin of safety based on the Ben Graham analysis?

Moderna, Inc.'s margin of safety is positive 841.9%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.